Source: Annual Congress 2011 - COPD: human studies
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Vaitkus, S. Lavinskiene, K. Bieksiene, J. Jeroch, R. Sakalauskas (Kaunas, Lithuania). Influence of AECOPD to ROS production in neutrophils. Eur Respir J 2011; 38: Suppl. 55, 736

Member's Comments

No comment yet.

Related content which might interest you: ROS production in PMN is higher during inflammation in NSCLC than in COPD Source: Annual Congress 2010 - Pathology of lung cancer Year: 2010 BALF modulates neutrophil phagocytosis and ROS production in different ways Source: Annual Congress 2009 - Airway inflammation and host defence Year: 2009 Analysis of reactive oxygen species in sputum neutrophils during acute exacerbation of COPD Source: Annual Congress 2012 - Inflammatory mechanisms in COPD Year: 2012 Induced sputum, but not BALF stimulated PMN ROS production is enhanced by ionomycin during COPD Source: Annual Congress 2010 - COPD and asthma: models and human studies Year: 2010 Xanthine oxidase inhibition reduces reactive nitrogen species production in COPD airways Source: Eur Respir J 2004; 23: 496 Year: 2004 Rhinovirus-induced cytokine production of circulating leukocytes is reduced in severe asthma Source: Virtual Congress 2020 – New insight into the immunology of asthma and COPD Year: 2020 ROS production in neutrophils is influenced by induced sputum and BAL fluid Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation Year: 2008 Increased production of reactive oxygen species of systemic PMN from COPD patients in comparison to healthy controls Source: Annual Congress 2010 - Novel mechanisms in COPD Year: 2010 Elevated mitochondrial reactive oxygen species in COPD macrophages at exacerbation Source: International Congress 2015 – Mucosal immunology: what’s new in 2015 Year: 2015 Cytokines and reactive oxygen species (ROS) produced by alveolar macrophages (AM) in sarcoidosis Source: Eur Respir J 2001; 18: Suppl. 33, 68s Year: 2001 Xanthine oxidase inhibition reduces reactive nitrogen species production in COPD airways Source: Eur Respir J 2003; 22: 457-461 Year: 2003 Aerobic training inhibits leukocytes production of oxidants, pro-inflammatory and pro-fibrotic factors reducing asthmatic phenotype Source: Annual Congress 2012 - Cell culture and animal models of lung disease Year: 2012 Apocynin reduces reactive oxygen species generation in airways of asthmatics Source: Annual Congress 2010 - New treatments for asthma and COPD Year: 2010 In vitro and in vivo modulation of NADPH oxidase activity and reactive oxygen species production in human neutrophils by a1-antitrypsin Source: ERJ Open Res, 7 (4) 00234-2021; 10.1183/23120541.00234-2021 Year: 2021 Respiratory syncytial-virus induced cytokine production from leukocytes is impaired in severe asthma Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man Year: 2021 Erdosteine affects eicosanoid production in asthma and COPD Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma Year: 2008 Inhibition of reactive nitrogen species production in COPD airways: comparison between steroid and theophylline Source: Eur Respir J 2005; 26: Suppl. 49, 293s Year: 2005 Altered mitochondrial reactive oxygen species (ROS) production in airway smooth muscle cells of severe asthma. Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of asthma Year: 2019 Hypoxia and reoxygenation modulate lung epithelial cell glutathione content, oxygen consumption and reactive oxygen species (ROS) production Source: Eur Respir J 2001; 18: Suppl. 33, 182s Year: 2001 Impaired haem oxygenase-1 expression in sputum macrophages of COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 748s Year: 2006